Semaglutide and Dapagliflozin in Diabetic Patients With Different Pathophysiology
Semaglutide and Dapagliflozin in Diabetic Patients With Different Pathophysiology
Active, not recruiting · NCT04451837 · Registry updated 2025-07-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Semaglutide and Dapagliflozin in Diabetic Patients With Different Pathophysiology | Type2 Diabetes | Active, not recruiting | Phase 2 | 2025-07-16 | NCT04451837 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Göteborg University | 174 |
| Region Skane | 168 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Anders Rosengrentest | Malmö | Sweden | 2 |